We report of a family who has three members affected by medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, one of whom sadly died in the neonatal period prior to diagnosis. Routine sequencing, available on a service basis in the UK, identified only a heterozygous mutation in ACADM gene (c.985A>G, p.Lys329Glu) in this family. Linkage analysis suggested a possible intragenic deletion which was confirmed by the use of array-based comparative genomic hybridization (aCGH). This second mutation was a large intragenic deletion encompassing at least exons 1–6 of the ACADM gene. Now that this deletion has been identified, several family members have come forward for carrier testing which was not possible previously. Larger deletions (20bp or more) have only previously been reported twice, but these may be a more frequent cause of MCAD deficiency than hitherto believed, due to fact that these are not anticipated and, therefore, the routine diagnostic techniques used will not identify them. This finding represents a useful learning point in the management of families with MCAD deficiency, and highlights that we should be routinely looking for larger deletions, when only one of the mutations can be identified on standard sequencing.
Medium Chain Acyl-CoA Dehydrogenase
Multiplex Ligation-dependent Probe Amplification
This is a preview of subscription content, log in to check access.
We would like to thank the family involved in this article.
Andresen BS, Dobrowolski SF, O'Reilly L et al (2001) Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 68:1408–1418PubMedCrossRefGoogle Scholar
Arnold GL, Saavedra-Matiz CA, Galvin-Parton PA et al (2010) Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. Mol Genet Metab 99:263–268PubMedCrossRefGoogle Scholar
Kennedy S, Potter BK, Wilson K et al (2010) The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening in Ontario. BMC Pediatr 10:82PubMedCrossRefGoogle Scholar
Maegawa GHB, Poplawski N, Andresen BS et al (2008) Interstitial deletion of 1p22.2-p31.1 and medium-chain acyl-CoA dehydrogenase deficiency in a patient with developmental delay. Am J Med Genet A 146A(12):1581–1586PubMedCrossRefGoogle Scholar
Maier EM, Liebl B, Roschinger W et al (2005) Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum Mutat 25:443–452PubMedCrossRefGoogle Scholar
Morris AAM, Taylor RW, Lightowlers RN et al (1995) Medium-chain acyl-CoA dehydrogenase deficiency caused by a deletion of exons 11 and 12. Hum Mol Genet 4:747–749PubMedCrossRefGoogle Scholar